NDA Almost Ready, MannKind Exubera(nt) About Chances For Inhaled-Insulin Partner
Despite safer-seeming profile, many skeptical of Afresa after flameout of Pfizer’s product.
Despite safer-seeming profile, many skeptical of Afresa after flameout of Pfizer’s product.